Gene therapy for lung cancer and mesothelioma

[21] Hoganson DK, 1996, CANCER RES, V56, P1315

[22] METABOLISM OF 5-FLUOROCYTOSINE TO 5-FLUOROURACIL IN HUMAN COLORECTAL TUMOR-CELLS TRANSDUCED WITH THE CYTOSINE DEAMINASE GENE - SIGNIFICANT ANTITUMOR EFFECTS WHEN ONLY A SMALL PERCENTAGE OF TUMOR-CELLS EXPRESS CYTOSINE DEAMINASE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) : 8302 - 8306

[23] GENE-THERAPY USING ADENOVIRUS CARRYING THE HERPES SIMPLEX-THYMIDINE KINASE GENE TO TREAT IN-VIVO MODELS OF HUMAN-MALIGNANT MESOTHELIOMA AND LUNG-CANCER [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (01) : 7 - 16

[24] KANEKO S, 1995, CANCER RES, V55, P5283

[25] KERN JA, 1990, CANCER RES, V50, P5184

[26] Kucharczuk JC, 1997, CANCER RES, V57, P466

[27] LIU TJ, 1994, CANCER RES, V54, P3662

[28] HERPES-SIMPLEX VIRUS TYPE-1 DELETION VARIANTS 1714 AND 1716 PINPOINT NEUROVIRULENCE-RELATED SEQUENCES IN GLASGOW STRAIN 17+ BETWEEN IMMEDIATE EARLY GENE-1 AND THE A SEQUENCE [J]. JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 631 - 639

[29] REDUCTION AND ELIMINATION OF ENCEPHALITIS IN AN EXPERIMENTAL GLIOMA THERAPY MODEL WITH ATTENUATED HERPES-SIMPLEX MUTANTS THAT RETAIN SUSCEPTIBILITY TO ACYCLOVIR [J]. NEUROSURGERY, 1993, 32 (04) : 597 - 603

[30] EXPERIMENTAL-THERAPY OF HUMAN GLIOMA BY MEANS OF A GENETICALLY ENGINEERED VIRUS MUTANT [J]. SCIENCE, 1991, 252 (5007) : 854 - 856

[21] Hoganson DK, 1996, CANCER RES, V56, P1315

[22] METABOLISM OF 5-FLUOROCYTOSINE TO 5-FLUOROURACIL IN HUMAN COLORECTAL TUMOR-CELLS TRANSDUCED WITH THE CYTOSINE DEAMINASE GENE - SIGNIFICANT ANTITUMOR EFFECTS WHEN ONLY A SMALL PERCENTAGE OF TUMOR-CELLS EXPRESS CYTOSINE DEAMINASE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) : 8302 - 8306

[23] GENE-THERAPY USING ADENOVIRUS CARRYING THE HERPES SIMPLEX-THYMIDINE KINASE GENE TO TREAT IN-VIVO MODELS OF HUMAN-MALIGNANT MESOTHELIOMA AND LUNG-CANCER [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (01) : 7 - 16

[24] KANEKO S, 1995, CANCER RES, V55, P5283

[25] KERN JA, 1990, CANCER RES, V50, P5184

[26] Kucharczuk JC, 1997, CANCER RES, V57, P466

[27] LIU TJ, 1994, CANCER RES, V54, P3662

[28] HERPES-SIMPLEX VIRUS TYPE-1 DELETION VARIANTS 1714 AND 1716 PINPOINT NEUROVIRULENCE-RELATED SEQUENCES IN GLASGOW STRAIN 17+ BETWEEN IMMEDIATE EARLY GENE-1 AND THE A SEQUENCE [J]. JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 631 - 639

[29] REDUCTION AND ELIMINATION OF ENCEPHALITIS IN AN EXPERIMENTAL GLIOMA THERAPY MODEL WITH ATTENUATED HERPES-SIMPLEX MUTANTS THAT RETAIN SUSCEPTIBILITY TO ACYCLOVIR [J]. NEUROSURGERY, 1993, 32 (04) : 597 - 603

[30] EXPERIMENTAL-THERAPY OF HUMAN GLIOMA BY MEANS OF A GENETICALLY ENGINEERED VIRUS MUTANT [J]. SCIENCE, 1991, 252 (5007) : 854 - 856